A detailed history of Rialto Wealth Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rialto Wealth Management, LLC holds 53 shares of ADPT stock, worth $896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Previous 60 11.67%
Holding current value
$896
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$6.83 - $12.16 $47 - $85
-7 Reduced 11.67%
53 $0
Q1 2025

Apr 10, 2025

BUY
$6.07 - $8.66 $364 - $519
60 New
60 $0

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.42B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Rialto Wealth Management, LLC Portfolio

Follow Rialto Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rialto Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rialto Wealth Management, LLC with notifications on news.